Skip to main content

Veru Inc.

VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000863894

In the last 90 days, Veru Inc. insiders filed 1 open-market purchase and 0 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $9.45M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Veru Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of VERU: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders65153−11
Shares3.53M322.1K3.56M+351.2K (+10.9%)
Value$12.6M$1.22M$7.63M−$3.78M (−33.1%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Veru Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to VERU in Q4 2025
InstitutionSharesValue% of portfolio
Alyeska Investment Group, L.P.1,000,000$2.14M0.01%
Jane Street Group, LLC71,667$153.4K0.00%
ADAR1 Capital Management, LLC35,000$74.9K0.01%
Mariner, LLC11,381$24.4K0.00%
Chung Wu Investment Group, LLC3,000$6.42K0.01%
Tower Research Capital LLC (TRC)1,270$2.72K0.00%
Lodestone Wealth Management LLC100$2140.00%

Sold out (18)

Institutions that held Veru Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (1)

Institutions that held Veru Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VERU in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Sheets Smith Investment Management322,084$1.22M